America's Best Nonprofits
  1. Home
  2. Medical Research
  3. Wichita, KS
  4. Arthritis Research Center Foundation

Arthritis Research Center Foundation

Arthritis Research Center Foundation is ranked among medical research organizations in Wichita, KS, with an America's Best Score of 65 out of 100, based on its 2024 Form 990.

  • Wichita, KS
  • Tax-exempt since 2000
  • EIN: 48-1223461
ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
65OF 100 Ranked in Wichita Medical Research How this score is calculated

Organization summary

Arthritis Research Center Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H51). Contributions are tax-deductible.

727 N Waco Ave Ste 200, Wichita, KS 67203-3953

Among the 3 scored medical research organizations in Wichita, Arthritis Research Center Foundation holds 2.3 months of operating reserves (peer median 2.3 months), runs a typical yearly surplus of 6.2% (peers: surplus of 0.2%), and has grown spending 4.8% a year (peers: grown spending 4.8% a year).

In fiscal year 2024 it reported $1,852,228 in revenue and $1,744,885 in expenses, with contributions making up 72.1% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2023 Form 990

To increase the general body of medical knowledge regarding rheumatic diseases (arthritis-related illnesses) by performing research using the data bank and publishing that research in peer-reviewed medical journals. The clinical research is designed to improve the treatment and outcomes of these conditions.

Largest programs · fiscal year 2023

  • Bristol myers squibb: To examine whether increases in gc dosage in response to increase in disease activity result in worse outcomes compared to changes/additions of other immunosuppressive medications in sle patients and health care utilization associated with levels of gc use. $48,373 spent · 3.4% of program spending
  • Mems-pfizer: To assess mtx and advanced therapy treatment adherence and characterize adherence patterns using electronic medication monitoring with medication event monitoring system (mems) in a cohort of ra patients being "newly treated" (<1 year since initiation) with po mtx, monotherapy or in combination with other agents, and tofacitanib, adalimumab, golimumab, and etanercept (<6 months since… Read more

    Mems-pfizer: To assess mtx and advanced therapy treatment adherence and characterize adherence patterns using electronic medication monitoring with medication event monitoring system (mems) in a cohort of ra patients being "newly treated" (<1 year since initiation) with po mtx, monotherapy or in combination with other agents, and tofacitanib, adalimumab, golimumab, and etanercept (<6 months since initiation)in a real-world setting.

    $42,538 spent · 3.0% of program spending
  • Ufcw: To understand how ufcw members in the us have been affected by the COVID-19 pandemic, including covid-related topics such as testing, illness outbreaks, and vaccination. $30,077 spent · 2.1% of program spending
  • All other program service initiatives, including registry that uses the internet to create a community of arthritis patients, who willingly provide patient information to be used for discovery research and the development of personalized medicine for people with arthritis, to gather data to be used for analyses of heart disease in rheumatoid arthritis and using the ndb ra patient date from 1998 th… Read more

    All other program service initiatives, including registry that uses the internet to create a community of arthritis patients, who willingly provide patient information to be used for discovery research and the development of personalized medicine for people with arthritis, to gather data to be used for analyses of heart disease in rheumatoid arthritis and using the ndb ra patient date from 1998 through June 2011 to determine the most common treatment pathways over the past decade and characterize the patients on these pathways.

    $1,305,112 spent · 91.5% of program spending

Where each dollar went · fiscal year 2023

Of every dollar it spent, 92¢ went to programs, 8¢ to management and 0¢ to fundraising.

  • Programs $1,426,100
  • Management $118,456
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score65 / 100
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves2.3 mo; 2.0 mo in cash1.6 / 25
Financial balance (median margin)+6.2%13.3 / 20
Transparency3 full 990s, latest TY202420 / 20
Program growth+4.8% / yr9.9 / 15
Track record26 years10 / 10
Debt load0.0% of assets10 / 10
Total64.8 → 65
Spending on programs
Not scored; America's Best needs 65%+
92%Meets

Compared with Wichita peers

MeasureThis organizationPeer median
Operating reserves2.3 mo2.3 mo
Typical margin+6.2%+0.2%
Spending growth+4.8% / yr+4.8% / yr
Debt load0.0%0.0%

Peers: the 3 Wichita medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$1,852,228Fiscal year 20242022: $1,048,15520222023: $1,693,48420232024: $1,852,2282024
Expenses$1,744,885Fiscal year 20242022: $1,588,37720222023: $1,544,55620232024: $1,744,8852024
Total assets$331,717Fiscal year 20242022: $75,54820222023: $224,37420232024: $331,7172024
Total liabilities$0Fiscal year 20242022: $10220222023: $020232024: $02024
Fiscal year ending December 2024
Revenue$1,852,228
Expenses$1,744,885
Net income$107,343
Net assets$331,717

Notable sources of revenue

Percent of total revenue
Contributions$1,335,642
Program services$508,339
Investment income$6,073
Other (net)$2,174

Assets / debt

Total assets$331,717
Total liabilities$0
Net assets$331,717

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$1,693,484
Expenses$1,544,556
Net income$148,928
Net assets$224,374

Notable sources of revenue

Percent of total revenue
Contributions$1,263,730
Program services$414,789
Investment income$5,236
Other (net)$9,729

Assets / debt

Total assets$224,374
Total liabilities$0
Net assets$224,374

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$1,048,155
Expenses$1,588,377
Net income−$540,222
Net assets$75,446

Notable sources of revenue

Percent of total revenue
Contributions$666,094
Program services$372,211
Investment income$4,150
Other (net)$5,700

Assets / debt

Total assets$75,548
Total liabilities$102
Net assets$75,446

Compensation

Officers and key employees$88,771
Share of expenses5.6%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?